Examination of Various Endogenous glucose-related hormones and glycemic variability in patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

Examination of Various Endogenous glucose-related hormones and glycemic variability in patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis - EVET2H study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045582

Enrollment

Registered

2021-09-27

Start date

2021-09-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 20 years old Patients undergoing hemodialysis Patients who have obtained written consent from the person

Exclusion criteria

Exclusion criteria: Patients who have taken oral hypoglycemic agents, insulin preparations, or GLP-1 receptor agonists within the past 7 days at the time of obtaining consent Long hemodialysis time, more than 4 hours Patients with allergies to wheat, butter, maltose, chicken eggs, soybeans, peaches, apples, walnuts, peanuts (which may be included in the manufacturing ingredients) and Mealtest S Patients with markedly impaired swallowing function Patients using a pacemaker

Design outcomes

Primary

Measure	Time frame
Area under the curve of pancreatic glucagon level measurements	—

Countries

Japan

Contacts

Public ContactKanori Iwamatsu

Tokai University School of Medicine Division of Nephrology, Endocrinology and Metabolism

k-iwamtsu@tsc.u-tokai.ac.jp0463-93-1121

Outcome results